Research continues despite impact of funding deficit

Article

A lack of dependable funding is threatening to create a deficit of highly skilled scientists at a time when the U.S. could face a health care crisis brought on by devastating disorders, according to results of a recent study.

Clarksburg, MD-BrightFocus Foundation has released the results of a survey of more than 170 biomedical scientists that explores the most significant barriers to progress in ending eye and brain diseases.

The survey indicates that a lack of dependable funding is threatening to create a deficit of highly skilled scientists at a time when the nation could soon face a health care crisis brought on by devastating disorders such as Alzheimer’s, macular degeneration, and glaucoma.

“Nearly 20 million people in the U.S. are affected by Alzheimer’s disease, macular degeneration, or glaucoma. That number is climbing with an aging population, threatening our families, our health care, and our economy. Eradicating these diseases should be a much higher national priority,” said Stacy Haller, president and chief executive officer of BrightFocus Foundation, formerly named American Health Assistance Foundation.

For details of the survey and results, go to www.brightfocus.org/ResearcherSurvey2013.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.